Post-market Observational Study Zenith® t-Branch™
1 other identifier
observational
80
2 countries
3
Brief Summary
The Zenith® t-Branch™ Thoracoabdominal Endovascular Graft Study is a post-market observational study to evaluate the performance of the Zenith® t-Branch™ in the treatment of thoracoabdominal aortic aneurysms in routine care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2014
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 2, 2014
CompletedFirst Posted
Study publicly available on registry
April 4, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2020
CompletedJanuary 27, 2020
January 1, 2020
3.9 years
April 2, 2014
January 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of mortality and morbidity
30 days
Study Arms (1)
Endovascular treatment
Zenith® t-Branch™ Thoracoabdominal Endovascular Graft
Interventions
Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guide the study device(s) into place in the aorta.
Eligibility Criteria
Hospitals
You may qualify if:
- Treated with the off-the-shelf Zenith® t-Branch™ Thoracoabdominal Endovascular Graft
- Signed informed consent
You may not qualify if:
- Inability or refusal to give informed consent by the patient or a legally authorized representative
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Universitäts Krankenhaus Eppendorf
Hamburg, D-20246, Germany
St. Franziscus Hospital-GmbH
Münster, D-48145, Germany
Skaane University Hospital
Malmo, S 205 02, Sweden
Related Publications (2)
Tsilimparis N, Bosiers M, Resch T, Torsello G, Austermann M, Rohlffs F, Coates B, Yeh C, Kolbel T. Two-year target vessel-related outcomes following use of off-the-shelf branched endografts for the treatment of thoracoabdominal aortic aneurysms. J Vasc Surg. 2023 Aug;78(2):289-298. doi: 10.1016/j.jvs.2023.03.498. Epub 2023 Apr 11.
PMID: 37044318DERIVEDBosiers M, Kolbel T, Resch T, Tsilimparis N, Torsello G, Austermann M. Early and midterm results from a postmarket observational study of Zenith t-Branch thoracoabdominal endovascular graft. J Vasc Surg. 2021 Oct;74(4):1081-1089.e3. doi: 10.1016/j.jvs.2021.01.070. Epub 2021 Mar 5.
PMID: 33684474DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giovanni B Torsello, M.D.
St. Franziscus Hospital-GmbH
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2014
First Posted
April 4, 2014
Study Start
January 1, 2014
Primary Completion
December 1, 2017
Study Completion
January 9, 2020
Last Updated
January 27, 2020
Record last verified: 2020-01